Whittier Trust CO Blueprint Medicines Corp Transaction History

Whittier Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$45.23 - $70.15 $768 - $1,192	-17 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$54.1 - $110.08 $919 - $1,871	17 New	17 $1,000
Q4 2019 Jan 31, 2020	SELL	$66.73 - $82.59 $108,903 - $134,786	-1,632 Closed	0 $0
Q3 2019 Oct 18, 2019	BUY	$72.9 - $101.41 $43,740 - $60,846	600 Added 58.14%	1,632 $120,000
Q2 2019 Jul 23, 2019	BUY	$73.54 - $97.8 $75,893 - $100,929	1,032 New	1,032 $97,000

350

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.66B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.